NCT00569504

Brief Summary

The purpose of this study is to assess the cross-sectional prevalence of the metabolic syndrome in patients with schizophrenia taking antipsychotics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2007

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 7, 2007

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

June 12, 2009

Status Verified

June 1, 2009

First QC Date

December 6, 2007

Last Update Submit

June 11, 2009

Conditions

Metabolic SyndromeSchizophrenia

Keywords

schizophreniaantipsychoticsmetabolic syndromeprevalence

Outcome Measures

Primary Outcomes (1)

  • metabolic syndrome

    cross-sectional

Secondary Outcomes (1)

  • each factor of metabolic syndrome

Study Arms (1)

A, observatoin

inpatients and outpatients in Seoul National Hospital

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

DSM-IV diagnosis of schizophrenia

You may qualify if:

  • Patients taking a same antipsychotics at least more than one year
  • schizophrenia or schizoaffective disorder

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National Hospital

Seoul, 139-757, South Korea

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood sampling

MeSH Terms

Conditions

Metabolic SyndromeSchizophrenia

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesSchizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Jong-il Lee, M.D.

    Seoul National Hospital

    STUDY DIRECTOR

Central Study Contacts

Shi Hyun Kang, M.D.

CONTACT

82-2-2204-0326drshe@hanmail.net

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

December 6, 2007

First Posted

December 7, 2007

Study Start

December 1, 2007

Study Completion

September 1, 2009

Last Updated

June 12, 2009

Record last verified: 2009-06

Locations

KR(1)